Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
IMGN | ImmunoGen, Inc. | Svp & Chief Commercial Officer | $2.21M | Nov 15, 2022 | ||
EFTR, EFTRW | eFFECTOR Therapeutics, Inc. | Director | Jun 13, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|